Information for "Protection and also Scientific Activity regarding Atezolizumab In addition Ipilimumab in In your neighborhood Superior or perhaps Metastatic NonSmall Cell Lung Cancer Comes from a Cycle 1b Trial"
From EECH Central
Basic information
Display title | Protection and also Scientific Activity regarding Atezolizumab In addition Ipilimumab in In your neighborhood Superior or perhaps Metastatic NonSmall Cell Lung Cancer Comes from a Cycle 1b Trial |
Default sort key | Protection and also Scientific Activity regarding Atezolizumab In addition Ipilimumab in In your neighborhood Superior or perhaps Metastatic NonSmall Cell Lung Cancer Comes from a Cycle 1b Trial |
Page length (in bytes) | 3,043 |
Page ID | 1437989 |
Page content language | English (en) |
Page content model | wikitext |
Indexing by robots | Allowed |
Number of redirects to this page | 0 |
Page protection
Edit | Allow all users (infinite) |
Move | Allow all users (infinite) |
Edit history
Page creator | Cellotrick5 (Talk | contribs) |
Date of page creation | 10:41, 4 May 2024 |
Latest editor | Cellotrick5 (Talk | contribs) |
Date of latest edit | 10:41, 4 May 2024 |
Total number of edits | 1 |
Total number of distinct authors | 1 |
Recent number of edits (within past 90 days) | 1 |
Recent number of distinct authors | 1 |